Rebuilt cancer drug strikes tumours hard, spares healthy cells
Newsweek - 04-Nov-2025SNA-engineered 5FU killed AML cells up to 20,000× more effectively with no detected toxicity
Join the club for FREE to access the whole archive and other member benefits.
Health reporter at Newsweek
Hannah Millington is a journalist specialising in health reporting for Newsweek, where she covers a wide range of stories linking scientific research, public-health developments and everyday wellbeing. She writes engaging and accessible articles that translate complex studies and medical findings into clear insight for general readers. With a focus on how health trends, behaviours and innovations intersect in people’s lives, her work helps readers make sense of emerging evidence and shifting landscapes in medicine and wellness.
Visit website: https://www.newsweek.com/authors/hannah-millington
See alsoDetails last updated 09-Nov-2025
SNA-engineered 5FU killed AML cells up to 20,000× more effectively with no detected toxicity